Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 18.18 | N/A |
| PEG Ratio (TTM) | -0.62 | N/A |
| P/S Ratio (TTM) | 1.34 | N/A |
| P/B Ratio (TTM) | 1.61 | N/A |
| P/FCF Ratio (TTM) | 8.11 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.84 | N/A |
| Price to 5YR AVG FCF Ratio | 7.13 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.30% | N/A |
| ROE (TTM) | 8.72% | N/A |
| Net Profit Margin (TTM) | 7.42% | N/A |
| ROIC 5YR AVG | 5.17% | N/A |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -20.75% | 104.42% | 87.51% |
| Revenue | -0.02% | -7.02% | -5.92% |
| Net Income | -20.09% | 107.50% | 89.80% |
| Cash Flow | 2.36% | -0.83% | -1.30% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.73 | N/A |
| Quick Ratio (TTM) | 0.67 | N/A |
| D/E Ratio (TTM) | 1.26 | N/A |
| Interest Coverage (TTM) | 2.86 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 0.80 | N/A |
| LTL to 5YR AVG FCF | 6.25 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.22% | N/A |